Our study demonstrated that patients with GC were characterized by a trend of differentiation from CD4+TN to CD4+TTM/TEM in PBLs, and a higher AMs and IMs expression on T cells in PBLs compared with HDs. This evidence concerns the gene CD4 and gastric cancer.